• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无机焦磷酸作为基质小泡对羟基磷灰石或二水焦磷酸钙矿物质沉积的调节剂。

Inorganic pyrophosphate as a regulator of hydroxyapatite or calcium pyrophosphate dihydrate mineral deposition by matrix vesicles.

作者信息

Thouverey C, Bechkoff G, Pikula S, Buchet R

机构信息

Department of Biochemistry, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.

出版信息

Osteoarthritis Cartilage. 2009 Jan;17(1):64-72. doi: 10.1016/j.joca.2008.05.020. Epub 2008 Jul 7.

DOI:10.1016/j.joca.2008.05.020
PMID:18603452
Abstract

OBJECTIVE

Pathological mineralization is induced by unbalance between pro- and anti-mineralization factors. In calcifying osteoarthritic joints, articular chondrocytes undergo terminal differentiation similar to that in growth plate cartilage and release matrix vesicles (MVs) responsible for hydroxyapatite (HA) or calcium pyrophosphate dihydrate (CPPD) deposition. Inorganic pyrophosphate (PP(i)) is a likely source of inorganic phosphate (P(i)) to sustain HA formation when hydrolyzed but also a potent inhibitor preventing apatite mineral deposition and growth. Moreover, an excess of PP(i) can lead to CPPD formation, a marker of pathological calcification in osteoarthritic joints. It was suggested that the P(i)/PP(i) ratio during biomineralization is a turning point between physiological and pathological mineralization. The aim of this work was to determine the conditions favoring either HA or CPPD formation initiated by MVs.

METHODS

MVs were isolated from 17-day-old chicken embryo growth plate cartilages and subjected to mineralization in the presence of various P(i)/PP(i) ratios. The mineralization kinetics and the chemical composition of minerals were determined, respectively, by light scattering and infrared spectroscopy.

RESULTS

The formation of HA is optimal when the P(i)/PP(i) molar ratio is above 140, but is completely inhibited when the ratio decreases below 70. The retardation of any mineral formation is maximal at P(i)/PP(i) ratio around 30. CPPD is exclusively produced by MVs when the ratio is below 6, but it is inhibited for the ratio exceeding 25.

CONCLUSIONS

Our findings are consistent with the P(i)/PP(i) ratio being a determinant factor leading to pathological mineralization or its inhibition.

摘要

目的

病理性矿化是由促矿化因子和抗矿化因子之间的失衡引起的。在钙化性骨关节炎关节中,关节软骨细胞经历类似于生长板软骨的终末分化,并释放负责羟基磷灰石(HA)或二水焦磷酸钙(CPPD)沉积的基质小泡(MVs)。无机焦磷酸(PP(i))在水解时可能是维持HA形成的无机磷酸盐(P(i))来源,但也是阻止磷灰石矿物沉积和生长的有效抑制剂。此外,过量的PP(i)可导致CPPD形成,这是骨关节炎关节病理性钙化的标志物。有人提出生物矿化过程中的P(i)/PP(i)比值是生理矿化和病理矿化之间的转折点。这项工作的目的是确定有利于MVs引发HA或CPPD形成的条件。

方法

从17日龄鸡胚生长板软骨中分离出MVs,并在存在各种P(i)/PP(i)比值的情况下进行矿化。分别通过光散射和红外光谱法测定矿化动力学和矿物质的化学成分。

结果

当P(i)/PP(i)摩尔比高于140时,HA的形成最佳,但当该比值降至70以下时则完全受到抑制。在P(i)/PP(i)比值约为30时,任何矿物质形成的延迟最大。当比值低于6时,CPPD仅由MVs产生,但当比值超过25时则受到抑制。

结论

我们的研究结果与P(i)/PP(i)比值是导致病理性矿化或其抑制的决定因素这一观点一致。

相似文献

1
Inorganic pyrophosphate as a regulator of hydroxyapatite or calcium pyrophosphate dihydrate mineral deposition by matrix vesicles.无机焦磷酸作为基质小泡对羟基磷灰石或二水焦磷酸钙矿物质沉积的调节剂。
Osteoarthritis Cartilage. 2009 Jan;17(1):64-72. doi: 10.1016/j.joca.2008.05.020. Epub 2008 Jul 7.
2
Dimethyl sulfoxide-induced hydroxyapatite formation: a biological model of matrix vesicle nucleation to screen inhibitors of mineralization.二甲基亚砜诱导的羟基磷灰石形成:用于筛选矿化抑制剂的基质小泡成核的生物学模型
Anal Biochem. 2008 Oct 1;381(1):123-8. doi: 10.1016/j.ab.2008.06.003. Epub 2008 Jun 5.
3
Up-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease.焦磷酸钙二水合物晶体沉积病患者关节透明软骨中软骨中间层蛋白和ANK的表达上调。
Arthritis Rheum. 2002 Dec;46(12):3218-29. doi: 10.1002/art.10632.
4
Nature of phosphate substrate as a major determinant of mineral type formed in matrix vesicle-mediated in vitro mineralization: An FTIR imaging study.磷酸底物的性质作为基质小泡介导的体外矿化中形成的矿物质类型的主要决定因素:一项傅里叶变换红外光谱成像研究。
Bone. 2006 Jun;38(6):811-7. doi: 10.1016/j.bone.2005.11.027. Epub 2006 Feb 3.
5
Sinomenine, theophylline, cysteine, and levamisole: Comparisons of their kinetic effects on mineral formation induced by matrix vesicles.青藤碱、茶碱、半胱氨酸和左旋咪唑:它们对基质小泡诱导的矿化形成的动力学效应比较。
J Inorg Biochem. 2010 Apr;104(4):446-54. doi: 10.1016/j.jinorgbio.2009.12.018. Epub 2010 Jan 4.
6
Pyrophosphate, phosphate ion interaction: effects on calcium pyrophosphate and calcium hydroxyapatite crystal formation in aqueous solutions.焦磷酸盐与磷酸根离子的相互作用:对水溶液中焦磷酸钙和羟基磷灰石晶体形成的影响
J Rheumatol. 1983 Oct;10(5):769-77.
7
Proteome analysis of matrix vesicles isolated from femurs of chicken embryo.从鸡胚股骨中分离出的基质小泡的蛋白质组分析。
Proteomics. 2008 Jan;8(1):192-205. doi: 10.1002/pmic.200700612.
8
Investigation of calcium crystals in OA knees.骨关节炎膝关节中钙晶体的研究。
Rheumatol Int. 2010 Mar;30(5):623-31. doi: 10.1007/s00296-009-1032-2. Epub 2009 Jul 29.
9
Distinct actions of strontium on mineral formation in matrix vesicles.锶对基质小泡中矿物质形成的不同作用。
Biochem Biophys Res Commun. 2008 Aug 29;373(3):378-81. doi: 10.1016/j.bbrc.2008.06.044. Epub 2008 Jun 23.
10
Ankylosing spondylitis, late osteoarthritis, vascular calcification, chondrocalcinosis and pseudo gout: toward a possible drug therapy.强直性脊柱炎、晚期骨关节炎、血管钙化、软骨钙质沉着症和假性痛风:一种可能的药物治疗方法。
Curr Med Chem. 2011;18(14):2196-203. doi: 10.2174/092986711795656153.

引用本文的文献

1
Pyrophosphate-Containing Calcium Phosphates Negatively Impact Heterotopic Bone Quality.含焦磷酸盐的磷酸钙对异位骨质量有负面影响。
Adv Healthc Mater. 2025 Jun;14(16):e2405171. doi: 10.1002/adhm.202405171. Epub 2025 May 22.
2
Building a digital library on research into mineralizing vesicles: a systematic review-based approach.构建关于矿化小泡研究的数字图书馆:一种基于系统综述的方法。
Biophys Rev. 2025 Feb 13;17(2):627-651. doi: 10.1007/s12551-025-01282-1. eCollection 2025 Apr.
3
Calcium Pyrophosphate Crystal Formation and Deposition: Where Do we Stand and What Does the Future hold?
焦磷酸钙晶体的形成和沉积:我们目前处于什么位置,未来又将如何?
Curr Rheumatol Rep. 2024 Oct;26(10):354-365. doi: 10.1007/s11926-024-01161-w. Epub 2024 Aug 1.
4
Tunable Enzyme-Assisted Mineralization of Apatitic Calcium Phosphate by Homogeneous Catalysis.通过均相催化实现磷灰石型磷酸钙的可调酶辅助矿化。
Int J Mol Sci. 2022 Dec 20;24(1):43. doi: 10.3390/ijms24010043.
5
NPP1 and TNAP hydrolyze ATP synergistically during biomineralization.NPP1 和 TNAP 在生物矿化过程中协同水解 ATP。
Purinergic Signal. 2023 Jun;19(2):353-366. doi: 10.1007/s11302-022-09882-2. Epub 2022 Jul 23.
6
Bone without borders - Monetite-based calcium phosphate guides bone formation beyond the skeletal envelope.无边界的骨骼——基于透钙磷石的磷酸钙引导骨骼在骨骼包膜之外形成。
Bioact Mater. 2022 Apr 6;19:103-114. doi: 10.1016/j.bioactmat.2022.03.012. eCollection 2023 Jan.
7
The Neuropeptide Spexin Promotes the Osteoblast Differentiation of MC3T3-E1 Cells via the MEK/ERK Pathway and Bone Regeneration in a Mouse Calvarial Defect Model.神经肽 Spexin 通过 MEK/ERK 通路促进 MC3T3-E1 细胞的成骨细胞分化,并在小鼠颅骨缺损模型中促进骨再生。
Tissue Eng Regen Med. 2022 Feb;19(1):189-202. doi: 10.1007/s13770-021-00408-2. Epub 2021 Dec 24.
8
Axial mechanical loading to mouse long bone regulates endochondral ossification and endosteal mineralization through activation of the BMP-Smad pathway during postnatal growth.对小鼠长骨施加轴向机械负荷可在出生后生长过程中通过激活骨形态发生蛋白(BMP)-Smad信号通路来调节软骨内成骨和骨内膜矿化。
Bone Rep. 2021 May 7;15:101088. doi: 10.1016/j.bonr.2021.101088. eCollection 2021 Dec.
9
Annexins A2, A6 and Fetuin-A Affect the Process of Mineralization in Vesicles Derived from Human Osteoblastic hFOB 1.19 and Osteosarcoma Saos-2 Cells. annexin A2、A6 和胎球蛋白-A 影响来源于人成骨细胞 hFOB 1.19 和骨肉瘤 Saos-2 细胞的小泡的矿化过程。
Int J Mol Sci. 2021 Apr 13;22(8):3993. doi: 10.3390/ijms22083993.
10
Hydrolysis of Extracellular ATP by Vascular Smooth Muscle Cells Transdifferentiated into Chondrocytes Generates P but Not PP.血管平滑肌细胞向软骨细胞转分化产生的 P 而不是 PP 水解细胞外 ATP。
Int J Mol Sci. 2021 Mar 14;22(6):2948. doi: 10.3390/ijms22062948.